AllianceBernstein
MIRM icon

AllianceBernstein’s Mirum Pharmaceuticals MIRM Stock Holding History

AllianceBernstein’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.88M Buy
49,180
+5,730
+13% +$539K ﹤0.01% 1663
2025
Q4 		$3.43M Hold
43,450
– – ﹤0.01% 1719
2025
Q3 		$3.19M Hold
43,450
– – ﹤0.01% 1746
2025
Q2 		$2.21M Buy
43,450
+1,600
+4% +$71.2K ﹤0.01% 1885
2025
Q1 		$1.89M Buy
41,850
+800
+2% +$37.7K ﹤0.01% 1936
2024
Q4 		$1.7M Hold
41,050
– – ﹤0.01% 2050
2024
Q3 		$1.6M Hold
41,050
– – ﹤0.01% 2089
2024
Q2 		$1.4M Buy
41,050
+16,950
+70% +$444K ﹤0.01% 2133
2024
Q1 		$605K Sell
24,100
-8,102
-25% -$223K ﹤0.01% 2500
2023
Q4 		$951K Sell
32,202
-6,634
-17% -$201K ﹤0.01% 2294
2023
Q3 		$1.23M Buy
38,836
+3,034
+8% +$83.1K ﹤0.01% 2132
2023
Q2 		$926K Buy
35,802
+11,702
+49% +$311K ﹤0.01% 2320
2023
Q1 		$579K Hold
24,100
– – ﹤0.01% 2495
2022
Q4 		$470K Buy
24,100
+3,500
+17% +$69.2K ﹤0.01% 2662
2022
Q3 		$433K Hold
20,600
– – ﹤0.01% 2715
2022
Q2 		$401K Hold
20,600
– – ﹤0.01% 2776
2022
Q1 		$454K Hold
20,600
– – ﹤0.01% 2720
2021
Q4 		$329K Buy
20,600
+3,900
+23% +$60.7K ﹤0.01% 2916
2021
Q3 		$333K Hold
16,700
– – ﹤0.01% 2922
2021
Q2 		$289K Buy
16,700
+1,800
+12% +$32.3K ﹤0.01% 3020
2021
Q1 		$295K Hold
14,900
– – ﹤0.01% 2914
2020
Q4 		$260K Buy
14,900
+1,500
+11% +$29.5K ﹤0.01% 2919
2020
Q3 		$258K Hold
13,400
– – ﹤0.01% 2872
2020
Q2 		$261K Buy
+13,400
New +$224K ﹤0.01% 2934
2019
Q4 		– Sell
-1,144,813
Closed -$11.5M – 3135
2019
Q3 		$11.5M Buy
+1,144,813
New +$14M 0.01% 991

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

AllianceBernstein's MIRM Position: Q1 2026 in Review

AllianceBernstein increased its Mirum Pharmaceuticals (MIRM) stake by 13% in Q1 2026, buying an estimated $539K and bringing the position to 49,180 shares worth $3.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

AllianceBernstein first reported a position in MIRM in Q3 2019 and has held it in 25 quarters since. The position peaked at $11.5M in Q3 2019. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • AllianceBernstein held 49,180 shares of Mirum Pharmaceuticals worth $3.88M as of Q1 2026.
  • AllianceBernstein bought 5,730 Mirum Pharmaceuticals shares in Q1 2026, an estimated $539K.
  • Mirum Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1663 holding.
  • AllianceBernstein first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 25 quarters since.
  • AllianceBernstein's Mirum Pharmaceuticals position peaked at $11.5M in Q3 2019.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.